This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Aslan and Zenyaku are teaming up to explore how eblasakimab’s mechanism of action differs from that of other biologic therapies for atopic dermatitis (AD).
Dr Bhutani presents the case of a 15-year-old female with long standing atopic dermatitis and discusses the importance of balancing parental preferences for "natural" agents with effective pharmaceutical options.
Silverberg, MD Molluscum Contagiosum appears to be on the rise and often travels with atopic dermatitis (AD). Topical isotretinoin, even when covering 90% of a patient’s body surface area, showed minimal systemic absorption. Watch Now The Lowdown on Molluscum Nanette B. Watch Now Biosimilars in Dermatology: Where Do They Fit in?
The Ministry of Health, Labor and Welfare (MHLW) in Japan has granted marketing and manufacturing authorization for dupilumab (Dupixent, Sanofi and Regeneron Pharmaceuticals, Inc.) for the treatment of chronic spontaneous urticaria (CSU) in people aged 12 years and older whose disease is not adequately controlled with existing therapy.
Atopic dermatitis (AD) patients who switched to upadacitinib (Rinvoq, AbbVie) from dupilumab (Dupixent, Regeneron, and Sanofi) hit higher treatment targets, according to results from Period 2 of the LEVEL UP study. The most frequently reported TEAEs included nasopharyngitis, acne, upper respiratory tract infection, and atopic dermatitis.
Silverberg, MD Molluscum Contagiosum appears to be on the rise and often travels with atopic dermatitis (AD). Topical isotretinoin, even when covering 90% of a patient’s body surface area, showed minimal systemic absorption. Watch Now The Lowdown on Molluscum Nanette B. Watch Now Biosimilars in Dermatology: Where Do They Fit in?
Atopic dermatitis (AD) is extremely common, but it can resemble psoriasis, urticaria, non-blistering immunobolus disease, cutaneous lymphoma, and many other skin conditions. Silverberg, MD Molluscum Contagiosum appears to be on the rise and often travels with atopic dermatitis (AD). Watch Now The Lowdown on Molluscum Nanette B.
Silverberg, MD Molluscum Contagiosum appears to be on the rise and often travels with atopic dermatitis (AD). Topical isotretinoin, even when covering 90% of a patient’s body surface area, showed minimal systemic absorption. Watch Now The Lowdown on Molluscum Nanette B. Watch Now Biosimilars in Dermatology: Where Do They Fit in?
Silverberg, MD Molluscum Contagiosum appears to be on the rise and often travels with atopic dermatitis (AD). Topical isotretinoin, even when covering 90% of a patient’s body surface area, showed minimal systemic absorption. Watch Now The Lowdown on Molluscum Nanette B. Watch Now Biosimilars in Dermatology: Where Do They Fit in?
Silverberg, MD Molluscum Contagiosum appears to be on the rise and often travels with atopic dermatitis (AD). Topical isotretinoin, even when covering 90% of a patient’s body surface area, showed minimal systemic absorption. Watch Now The Lowdown on Molluscum Nanette B. Watch Now Biosimilars in Dermatology: Where Do They Fit in?
Raj Chovatiya, MD, PhD Atopic dermatitis (AD) is extremely common, but it can resemble psoriasis, urticaria, non-blistering immunobolus disease, cutaneous lymphoma, and many other skin conditions. Silverberg, MD Molluscum Contagiosum appears to be on the rise and often travels with atopic dermatitis (AD).
Genodermatoses can masquerade as atopic dermatitis (AD). Raj Chovatiya, MD, PhD Atopic dermatitis (AD) is extremely common, but it can resemble psoriasis, urticaria, non-blistering immunobolus disease, cutaneous lymphoma, and many other skin conditions. Watch Now Think Twice: Is It Really AD?
Raj Chovatiya, MD, PhD Atopic dermatitis (AD) is extremely common, but it can resemble psoriasis, urticaria, non-blistering immunobolus disease, cutaneous lymphoma, and many other skin conditions. Watch Now Pro Pearls for Diagnosing Genodermatoses Elizabeth Swanson, MD Genodermatoses can masquerade as atopic dermatitis (AD).
Raj Chovatiya, MD, PhD Atopic dermatitis (AD) is extremely common, but it can resemble psoriasis, urticaria, non-blistering immunobolus disease, cutaneous lymphoma, and many other skin conditions. Watch Now Pro Pearls for Diagnosing Genodermatoses Elizabeth Swanson, MD Genodermatoses can masquerade as atopic dermatitis (AD).
In this era of readily available pharmaceutical products for every imaginable ailment, it can be easy to default to the drug store when we need relief. Medieval Persian pharmaceutical manuscripts refer to 1200 types of oxymel. It has not always been that way. Reposted from: [link]
Watch Now [the_ad id="9263"] [the_ad id="9265"] Pro Pearls for Diagnosing Genodermatoses Elizabeth Swanson, MD Genodermatoses can masquerade as atopic dermatitis (AD). Silverberg, MD Molluscum Contagiosum appears to be on the rise and often travels with atopic dermatitis (AD). Watch Now The Lowdown on Molluscum Nanette B.
Watch Now [the_ad id="9263"] [the_ad id="9265"] Pro Pearls for Diagnosing Genodermatoses Elizabeth Swanson, MD Genodermatoses can masquerade as atopic dermatitis (AD). Silverberg, MD Molluscum Contagiosum appears to be on the rise and often travels with atopic dermatitis (AD). Watch Now The Lowdown on Molluscum Nanette B.
Watch Now [the_ad id="9263"] [the_ad id="9265"] Pro Pearls for Diagnosing Genodermatoses Elizabeth Swanson, MD Genodermatoses can masquerade as atopic dermatitis (AD). Silverberg, MD Molluscum Contagiosum appears to be on the rise and often travels with atopic dermatitis (AD). Watch Now The Lowdown on Molluscum Nanette B.
Raj Chovatiya, MD, PhD Atopic dermatitis (AD) is extremely common, but it can resemble psoriasis, urticaria, non-blistering immunobolus disease, cutaneous lymphoma, and many other skin conditions. Silverberg, MD Molluscum Contagiosum appears to be on the rise and often travels with atopic dermatitis (AD).
Raj Chovatiya, MD, PhD Atopic dermatitis (AD) is extremely common, but it can resemble psoriasis, urticaria, non-blistering immunobolus disease, cutaneous lymphoma, and many other skin conditions. Silverberg, MD Molluscum Contagiosum appears to be on the rise and often travels with atopic dermatitis (AD).
Here’s a review of 10 natural antimicrobials you can reach for as a first line of defense, before resorting to a pharmaceutical antibiotic. At present, cranberry supplementation can safely be suggested as complementary therapy in women with recurrent UTIs.” Some of your immune cells produce hydrogen peroxide to destroy pathogens.
Alys Pharmaceuticals, Inc. Alys combines six asset-centric Medicxi companies including Al Aldena Therapeutics, Graegis Pharmaceuticals, Granular Therapeutics, Klirna Biotech, Nira Biosciences and Vimela Therapeutics. ” The post Get to Know Alys Pharmaceuticals, Inc. appeared first on The Dermatology Digest.
Dandruff (Seborrheic Dermatitis) Dandruff, medically known as seborrheic dermatitis , is a common scalp condition marked by excessive shedding of skin cells. Skin Conditions (Eczema, Psoriasis, Contact Dermatitis) as Causes of Dry, Itchy Scalp Various skin conditions can lead to a dry, itchy scalp: a.
1 Explanations for the decline included poor compliance, poor reimbursement, fear of skin cancer, and the promise of newer therapies, said Dr. Richard. After at least 12 weeks of concomitant combination therapy, their facial vitiligo scores improved, and their total body vitiligo scores improved. It’s a great adjunct therapy.
AD: New topicals for kids “The most exciting new research is in the realm of topical therapies for atopic dermatitis (AD) in children,” shares Peter A. He hopes that 2024 ushers in the “virtuous cycle of therapy” for AD patients. “Now we have a delivery system for what was experimental and off-label.”
AD: New topicals for kids “The most exciting new research is in the realm of topical therapies for atopic dermatitis (AD) in children,” shares Peter A. He hopes that 2024 ushers in the “virtuous cycle of therapy” for AD patients. “Now we have a delivery system for what was experimental and off-label.”
This will be a game-changer if it pans out and may get us closer to disease cures via optimization of existing biological therapies,” he says. Dupilumab (Dupixent, Regeneron Pharmaceuticals, Inc., Hands Up for New CHE therapies Chronic hand eczema (CHE) will also get some love in 2024. And the Skin Disease of the Year Is….
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content